Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Gene therapy for cardiovascular applications

The major target indications of biopharmaceuticals currently undergoing clinical trials include cancer, cardiovascular, and infectious diseases, the major killers within the developed world. Although in excess of 30 nucleic acid-based drugs are currently being evaluated for gene therapy, vaccines, and other applications, the majority remain in the early stages of clinical development (phase I/II) [11]. [Pg.1380]

See other pages where Gene therapy for cardiovascular applications is mentioned: [Pg.227]    [Pg.229]    [Pg.231]    [Pg.233]    [Pg.235]    [Pg.237]    [Pg.239]    [Pg.241]    [Pg.227]    [Pg.229]    [Pg.231]    [Pg.233]    [Pg.235]    [Pg.237]    [Pg.239]    [Pg.241]    [Pg.83]    [Pg.83]    [Pg.215]    [Pg.29]    [Pg.465]    [Pg.511]    [Pg.476]    [Pg.575]    [Pg.205]    [Pg.564]    [Pg.1122]    [Pg.420]    [Pg.357]    [Pg.550]    [Pg.654]    [Pg.430]    [Pg.183]    [Pg.2794]    [Pg.236]    [Pg.348]    [Pg.171]    [Pg.459]   


SEARCH



Applications Therapies

Gene therapy

Gene therapy for

© 2024 chempedia.info